VBIO
Valion Bio
$0.28
−$0.01 (−4.71%)Jul 27, 2026
Key metrics
The numbers that frame VBIO today
- Market cap
- $905.83K
- P/E (TTM)
- -0.1
- EV / FCF
- -0.9
- Gross margin
- 71.4%
- EV / Sales
- -148.0
- ROIC
- -87.3%
- Div yield
- 0%
- Debt / equity
- 1.5
- 52wk Low
- $0.25
- 52wk High
- $5.60
Growth
Revenue and earnings trend for VBIO
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VBIO
Is Valion Bio a good buy?
No. Valion Bio has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks weak. That could put pressure on the long-term business case. We think Valion Bio is selling at a very high price.
What is the market capitalization of VBIO?
Valion Bio's market capitalization is $905.83K.
What is the P/E ratio for VBIO stock?
Valion Bio's current P/E ratio is -0.1.
What is the 52-week high for VBIO stock?
The 52-week high for Valion Bio is $5.60. The current close of $0.28 is 94.9% below that high.
What is the 52-week low for VBIO stock?
The 52-week low for Valion Bio is $0.25. The current close of $0.28 is 11.9% above that low.
Does VBIO stock pay dividends?
Valion Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VBIO?
Valion Bio's Debt / Equity ratio is 1.54.